These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 17021582)

  • 1. Osteogenesis imperfecta and its molecular diagnosis by determination of mutations of type I collagen genes.
    Tedeschi E; Antoniazzi F; Venturi G; Zamboni G; Tatò L
    Pediatr Endocrinol Rev; 2006 Sep; 4(1):40-6. PubMed ID: 17021582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.
    Xia XY; Cui YX; Huang YF; Pan LJ; Yang B; Wang HY; Li XJ; Shi YC; Lu HY; Zhou YC
    Clin Chim Acta; 2008 Dec; 398(1-2):148-51. PubMed ID: 18755172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
    Gajko-Galicka A
    Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteogenesis imperfecta: clinical, biochemical and molecular findings.
    Venturi G; Tedeschi E; Mottes M; Valli M; Camilot M; Viglio S; Antoniazzi F; Tatò L
    Clin Genet; 2006 Aug; 70(2):131-9. PubMed ID: 16879195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta.
    Lee KS; Song HR; Cho TJ; Kim HJ; Lee TM; Jin HS; Park HY; Kang S; Jung SC; Koo SK
    Hum Mutat; 2006 Jun; 27(6):599. PubMed ID: 16705691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy approaches for osteogenesis imperfecta.
    Niyibizi C; Wang S; Mi Z; Robbins PD
    Gene Ther; 2004 Feb; 11(4):408-16. PubMed ID: 14724682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COL1A1 mutation analysis in Lithuanian patients with osteogenesis imperfecta.
    Benusiené E; Kucinskas V
    J Appl Genet; 2003; 44(1):95-102. PubMed ID: 12590186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.
    Hartikka H; Kuurila K; Körkkö J; Kaitila I; Grénman R; Pynnönen S; Hyland JC; Ala-Kokko L
    Hum Mutat; 2004 Aug; 24(2):147-54. PubMed ID: 15241796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
    Ries-Levavi L; Ish-Shalom T; Frydman M; Lev D; Cohen S; Barkai G; Goldman B; Byers P; Friedman E
    Hum Mutat; 2004 Apr; 23(4):399-400. PubMed ID: 15024745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV.
    Pollitt R; McMahon R; Nunn J; Bamford R; Afifi A; Bishop N; Dalton A
    Hum Mutat; 2006 Jul; 27(7):716. PubMed ID: 16786509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteogenesis imperfecta: prospects for molecular therapeutics.
    Forlino A; Marini JC
    Mol Genet Metab; 2000; 71(1-2):225-32. PubMed ID: 11001814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV.
    Ward LM; Lalic L; Roughley PJ; Glorieux FH
    Hum Mutat; 2001 May; 17(5):434. PubMed ID: 11317364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
    Tanaka H
    Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct sequencing of PCR products for mutation detection in osteogenesis imperfecta.
    Galicka A; Gindzieński A
    J Appl Genet; 2002; 43(3):365-9. PubMed ID: 12177526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
    Garnero P; Schott AM; Prockop D; Chevrel G
    Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteogenesis imperfecta at the beginning of bone and joint decade.
    Primorac D; Rowe DW; Mottes M; Barisić I; Anticević D; Mirandola S; Gomez Lira M; Kalajzić I; Kusec V; Glorieux FH
    Croat Med J; 2001 Aug; 42(4):393-415. PubMed ID: 11471191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oesteogenesis imperfecta--genetics, diagnosis and medical treatment].
    Brixen KT; Illum NO; Hansen B; Lund AM; Mosekilde L
    Ugeskr Laeger; 2007 Jan; 169(1):30-4. PubMed ID: 17217883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular diagnosis of osteogenesis imperfecta type I].
    Galicka A; Bielawski T; Gindzieński A; Sredzińska K
    Pol Merkur Lekarski; 2008 Oct; 25(148):345-8. PubMed ID: 19145934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta.
    Rauch F; Lalic L; Roughley P; Glorieux FH
    J Bone Miner Res; 2010 Jun; 25(6):1367-74. PubMed ID: 19929435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteogenesis imperfecta and achievements in cell and gene therapy].
    Marijanović I; Radnić M; Matić I; Erceg-Ivkosić I
    Acta Med Croatica; 2010 Jul; 64(3):191-200. PubMed ID: 20922862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.